Bioxyne Ltd has released a press release.
Investor Presentation Update
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Bioxyne
- Enters German Market Euro3.2m Manufacturing & Supply Agmt
- Certificate GMP Compliance EU, UK, Singapore & Canada
- FY25 Revenue Guidance Upgrade
- BXN Signs Exclusive $7m Manufacturing and Supply Agreement
- Bioxyne Raises A$3 million in Capital Raise
Later from Bioxyne
- Bioxyne Updated Investor Presentation
- 30 June 2025 Appendix 4C Revised
- Preliminary Final Report
- FY2025 Results Presentation
- BXN Full Year 2026 Guidance
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne